Clinical trial

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

NCT00744549

Study summary

ClinicalTrials.gov

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIETARY_SUPPLEMENT · Unmapped registry intervention Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-05-01

PhasePHASE2

Conditions

Cancer of the Prostateunresolved

Prostate Cancerverified · MONDO: prostate cancer

Prostatic Neoplasmsunresolved

Interventions

Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin EDIETARY_SUPPLEMENT

PlaceboDRUG

Sponsors & collaborators

University Health Network, Torontolead sponsor

The Prostate Cancer Research Foundation of Canadacollaborator

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00744549 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.